Use of Cellulase to Improve Viscosity Control of Dissolving Pulp
Summary
The European Patent Office published patent application EP3365493A1 by Novozymes A/S for the use of cellulase enzymes to improve viscosity control of dissolving pulp. The patent covers methods of treating pulp with cellulase to achieve desired viscosity characteristics in paper manufacturing processes. The application was published April 8, 2026.
What changed
EPO published patent application EP3365493A1 for Novozymes A/S relating to the use of cellulase enzymes to improve viscosity control of dissolving pulp. The patent covers treatment methods where cellulase is applied to pulp to achieve desired viscosity characteristics.
Manufacturers in the pulp and paper industry should note this patent grant, as it establishes intellectual property rights that may affect enzyme-based processing methods in European markets. Companies developing similar cellulase applications for pulp viscosity control should review this patent for potential licensing requirements or design-around considerations.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
USE OF CELLULASE TO IMPROVE VISCOSITY CONTROL OF DISSOLVING PULP
Publication EP3365493A1 Kind: A1 Apr 08, 2026
Applicants
Novozymes A/S
Inventors
LOUREIRO, Pedro, Emanuel, Garcia, LUND, Henrik
IPC Classifications
D21C 3/00 20060101AFI20170508BHEP D21C 3/24 20060101ALI20170508BHEP D21C 3/26 20060101ALI20170508BHEP C12N 9/42 20060101ALI20170508BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.